Gene: EPHA8
Official Full Name: EPH receptor A8provided by HGNC
Gene Summary: This gene encodes a member of the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. The protein encoded by this gene functions as a receptor for ephrin A2, A3 and A5 and plays a role in short-range contact-mediated axonal guidance during development of the mammalian nervous system. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38014 | EPHA8 Knockout cell line (HEK293) | Human | EPHA8 | 1:3~1:6 | Negative | Online Inquiry |
EPHA8 Gene Knockout Cell Lines are advanced biological tools developed to facilitate the study of the ephrin receptor family, specifically the EphA8 receptor, which is implicated in various cellular processes including cell adhesion, migration, and proliferation. These cell lines are engineered to have a targeted deletion of the EPHA8 gene, enabling researchers to investigate the functional consequences of EphA8 signaling in a controlled environment.
The key mechanism of these cell lines lies in their ability to accurately model the effects of loss-of-function mutations on cellular behavior. By providing a system where EPHA8 is specifically knocked out, researchers can explore the downstream signaling pathways affected by this receptor and how its absence impacts processes such as tumorigenesis or neurodevelopmental disorders. This can be particularly important in cancer research, where aberrant EphA receptor signaling is often linked to tumor progression and metastasis.
The scientific importance of EPHA8 Gene Knockout Cell Lines extends to their wide range of applications in both research and clinical contexts. They serve as valuable assets in drug discovery, allowing for the identification of novel therapeutic targets and the testing of compounds that can modulate EphA8 activity. Moreover, by understanding the role of EPHA8 in disease mechanisms, these cell lines can contribute to the development of targeted therapies for conditions where EphA signaling is dysregulated.
What sets these cell lines apart from alternatives is their high specificity and reliability. Traditional models may not fully recapitulate the genetic context of human cells or may introduce off-target effects. In contrast, our EPHA8 Gene Knockout Cell Lines are rigorously validated to ensure they represent a true knockout phenotype, allowing for confidence in experimental outcomes.
For researchers and clinicians alike, these cell lines present a unique opportunity to deepen their understanding of how EphA8 contributes to health and disease, opening up new avenues for exploration. Their ability to shed light on complex biological processes while providing clear insights into potential therapeutic interventions makes them an invaluable resource.
Our company specializes in the production of high-caliber genetic models and tools, equipped with state-of-the-art technology and expert knowledge in genetic engineering. We are committed to empowering the scientific community with the resources needed to advance research and clinical applications in molecular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.